PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.42
ESG score near Healthcare median of 61.54. David Dodd would investigate if industry-standard ESG practices adequately address sector-specific risks.
57.61
Environmental score near Healthcare median of 58.33. David Dodd would investigate if industry-standard environmental practices adequately address climate risks.
61.21
Social score near Healthcare median of 63.48. David Dodd would investigate if industry-standard social practices adequately address stakeholder risks.
62.44
Governance score near Healthcare median of 62.59. David Dodd would investigate if industry-standard governance adequately protects shareholder interests.